| Developers: | Biotronik |
| Date of the premiere of the system: | December, 2020 |
| Branches: | Pharmaceutics, medicine, health care |
The announcement of Vital Data Sensor - the implant measuring activity of heart and body temperature
In the middle of December, 2020 the Biotronik company released the implant of Vital Data Sensor implanted under a thorax which measures activity of heart and body temperature. This sensor is an element of the new injection cardiomonitor (PCM) Biomonitor IIIm of Biotronik company.
Biomonitor IIIm includes several built-in sensors for measurement of heart rate and body temperature. The interrelation between these vital indicators and the state of health is well-known: so, fever often leads to increase in mid frequency of pulse and pulse rate at rest, thereby exhausting a functional reserve of the patient. A new system allows doctors to receive daily reports on fluctuations of body temperature of the patient and developing of cardiac arrhythmia. Such approach allows to monitor a status of patients with heart diseases and to reveal disturbing signs, without causing them from the house.
For the first time Biomonitor IIIm in the USA was used by doctor Luigi Di Biase, the head of department of electrophysiology and the director of service of the arhythmic help in Montefiore Health System. He noted that his patients because of a set of associated diseases are in group of high risk of complications COVID-19 during a pandemic. However thanks to the Biomonitor IIIm system attending physicians could reveal early symptoms of potentially life-threatening infection and, perhaps, to save several lives.
 | Technologies of remote monitoring of vital indicators help us to carry out diagnostics of a number of diseases. Considering additional influence of the current pandemic on health of patients with heart diseases, we decided to bring to the market unique touch Biomonitor IIIm technology as soon as possible, - the head of medical department of Biotronik Dr. David Hayes in the press release notes. - Patients with heart diseases treat group of the increased risk, and more careful observation will help doctors to cope with potential complications of COVID-19.[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |